These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

370 related items for PubMed ID: 18084344

  • 1. Antagonists of growth-hormone-releasing hormone: an emerging new therapy for cancer.
    Schally AV, Varga JL, Engel JB.
    Nat Clin Pract Endocrinol Metab; 2008 Jan; 4(1):33-43. PubMed ID: 18084344
    [Abstract] [Full Text] [Related]

  • 2. Dose-dependent growth inhibition in vivo of PC-3 prostate cancer with a reduction in tumoral growth factors after therapy with GHRH antagonist MZ-J-7-138.
    Heinrich E, Schally AV, Buchholz S, Rick FG, Halmos G, Mile M, Groot K, Hohla F, Zarandi M, Varga JL.
    Prostate; 2008 Dec 01; 68(16):1763-72. PubMed ID: 18729085
    [Abstract] [Full Text] [Related]

  • 3. Antagonists of growth hormone releasing hormone (GHRH) and of bombesin/gastrin releasing peptide (BN/GRP) suppress the expression of VEGF, bFGF, and receptors of the EGF/HER family in PC-3 and DU-145 human androgen-independent prostate cancers.
    Stangelberger A, Schally AV, Varga JL, Hammann BD, Groot K, Halmos G, Cai RZ, Zarandi M.
    Prostate; 2005 Aug 01; 64(3):303-15. PubMed ID: 15754342
    [Abstract] [Full Text] [Related]

  • 4. Inhibition of proliferation of PC-3 human prostate cancer by antagonists of growth hormone-releasing hormone: lack of correlation with the levels of serum IGF-I and expression of tumoral IGF-II and vascular endothelial growth factor.
    Plonowski A, Schally AV, Letsch M, Krupa M, Hebert F, Busto R, Groot K, Varga JL.
    Prostate; 2002 Aug 01; 52(3):173-82. PubMed ID: 12111694
    [Abstract] [Full Text] [Related]

  • 5. Antagonists of growth hormone-releasing hormone inhibit the proliferation of experimental non-small cell lung carcinoma.
    Szereday Z, Schally AV, Varga JL, Kanashiro CA, Hebert F, Armatis P, Groot K, Szepeshazi K, Halmos G, Busto R.
    Cancer Res; 2003 Nov 15; 63(22):7913-9. PubMed ID: 14633721
    [Abstract] [Full Text] [Related]

  • 6. Antagonists of growth hormone-releasing hormone in oncology.
    Schally AV, Varga JL.
    Comb Chem High Throughput Screen; 2006 Mar 15; 9(3):163-70. PubMed ID: 16533148
    [Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10. The expression of growth hormone-releasing hormone (GHRH) and splice variants of its receptor in human gastroenteropancreatic carcinomas.
    Busto R, Schally AV, Varga JL, Garcia-Fernandez MO, Groot K, Armatis P, Szepeshazi K.
    Proc Natl Acad Sci U S A; 2002 Sep 03; 99(18):11866-71. PubMed ID: 12186980
    [Abstract] [Full Text] [Related]

  • 11. Novel antagonists of growth hormone-releasing hormone inhibit growth and vascularization of human experimental ovarian cancers.
    Klukovits A, Schally AV, Szalontay L, Vidaurre I, Papadia A, Zarandi M, Varga JL, Block NL, Halmos G.
    Cancer; 2012 Feb 01; 118(3):670-80. PubMed ID: 21751186
    [Abstract] [Full Text] [Related]

  • 12. Antagonists of growth hormone-releasing hormone and somatostatin analog RC-160 inhibit the growth of the OV-1063 human epithelial ovarian cancer cell line xenografted into nude mice.
    Chatzistamou I, Schally AV, Varga JL, Groot K, Armatis P, Busto R, Halmos G.
    J Clin Endocrinol Metab; 2001 May 01; 86(5):2144-52. PubMed ID: 11344219
    [Abstract] [Full Text] [Related]

  • 13. Inhibition of proliferation in human MNNG/HOS osteosarcoma and SK-ES-1 Ewing sarcoma cell lines in vitro and in vivo by antagonists of growth hormone-releasing hormone: effects on insulin-like growth factor II.
    Braczkowski R, Schally AV, Plonowski A, Varga JL, Groot K, Krupa M, Armatis P.
    Cancer; 2002 Oct 15; 95(8):1735-45. PubMed ID: 12365022
    [Abstract] [Full Text] [Related]

  • 14. Inhibitory effect of antagonists of bombesin and growth hormone-releasing hormone on orthotopic and intraosseous growth and invasiveness of PC-3 human prostate cancer in nude mice.
    Stangelberger A, Schally AV, Varga JL, Zarandi M, Szepeshazi K, Armatis P, Halmos G.
    Clin Cancer Res; 2005 Jan 01; 11(1):49-57. PubMed ID: 15671527
    [Abstract] [Full Text] [Related]

  • 15. Extrapituitary effects of the growth hormone-releasing hormone.
    Kiaris H, Schally AV, Kalofoutis A.
    Vitam Horm; 2005 Jan 01; 70():1-24. PubMed ID: 15727800
    [Abstract] [Full Text] [Related]

  • 16. Combination of GHRH antagonists and docetaxel shows experimental effectiveness for the treatment of triple-negative breast cancers.
    Seitz S, Rick FG, Schally AV, Treszl A, Hohla F, Szalontay L, Zarandi M, Ortmann O, Engel JB, Buchholz S.
    Oncol Rep; 2013 Jul 01; 30(1):413-8. PubMed ID: 23624870
    [Abstract] [Full Text] [Related]

  • 17. Expression of growth hormone-releasing hormone and its receptor splice variants in human prostate cancer.
    Halmos G, Schally AV, Czompoly T, Krupa M, Varga JL, Rekasi Z.
    J Clin Endocrinol Metab; 2002 Oct 01; 87(10):4707-14. PubMed ID: 12364462
    [Abstract] [Full Text] [Related]

  • 18. Expression of growth hormone-releasing hormone receptor splicing variants in human primary adrenocortical tumours.
    Freddi S, Arnaldi G, Fazioli F, Scarpelli M, Appolloni G, Mancini T, Kola B, Bertagna X, Mantero F, Collu R, Boscaro M.
    Clin Endocrinol (Oxf); 2005 May 01; 62(5):533-8. PubMed ID: 15853821
    [Abstract] [Full Text] [Related]

  • 19. The combination of antagonists of LHRH with antagonists of GHRH improves inhibition of androgen sensitive MDA-PCa-2b and LuCaP-35 prostate cancers.
    Stangelberger A, Schally AV, Zarandi M, Heinrich E, Groot K, Havt A, Kanashiro CA, Varga JL, Halmos G.
    Prostate; 2007 Sep 01; 67(12):1339-53. PubMed ID: 17624923
    [Abstract] [Full Text] [Related]

  • 20. Characterization of receptors for growth hormone-releasing hormone in human osteosarcomas and Ewing's sarcomas.
    Halmos G, Schally AV, Bernardino AL, Varga JL.
    Int J Oncol; 2006 Aug 01; 29(2):463-9. PubMed ID: 16820890
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 19.